ASML Climbs After Record Q3 as CFO Fights China Curbs: “Common Sense Will Prevail”
ASML reported record Q3 sales of €11.7B with a 57.5% gross margin, raising 2026 guidance to €44B-€45B. Demand for AI-driven products exceeds planned 2027-2028 supply. U.S. policy risks include potential DUV sales restrictions in China. Q4 sales are expected between €14.2B-€15.2B.
How this was made

The 30-second read
Why it matters
The record quarter and raised guidance highlight robust demand, but policy risk from US export controls could limit future growth.
Market read
ASML's earnings beat and guidance lift are material for chip equipment investors; the stock is up 1% on the news.
What to watch
The CFO's opposition to the MATCH Act may signal regulatory headwinds not fully priced in.
Background
ASML is the sole supplier of extreme‑ultraviolet lithography machines, a critical component for advanced semiconductor manufacturing.
Ticker impact
ASML reported record Q3 sales of €11.7 bn, 57.5% gross margin and raised 2026 guidance to €44‑45 bn, a fresh earnings disclosure.
likely upward pressure as the market prices in the higher guidance and record margins
The earnings beat and guidance lift are new information that directly affect valuation; investors typically bid the stock higher on such news.
Market effects
Boosts outlook for the semiconductor equipment sector as AI demand accelerates.
European tech stocks may see a lift from ASML's strong performance.
Reinforces bullish bias on global chip‑making supply chain.
Counterpoint
Execution risk and potential US restrictions on DUV sales to China could temper upside.
Key entities
- ExecutiveRoger Dassen
CFO of ASML, publicly opposed the US MATCH Act restricting DUV sales to China.
_1.jpg&w=2048&q=75)



